Respiratory manganese particle size, time-course and neurobehavioral outcomes in workers at a manganese alloy production plant

NeuroToxicology

Volumn 45, Issue , 2014, Pages 276-284

  Park, Robert M ^a   Bouchard, Maryse F ^b,c   Baldwin, Mary ^b   Bowler, Rosemarie ^d   Mergler, Donna ^b  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

^d SAN FRANCISCO STATE UNIVERSITY   (United States)

Author keywords

Burden; Fume; Half life; Homeostasis; Manganese

Indexed keywords

MANGANESE; SILICON; AIR POLLUTANT; FERRO-MANGANESE ALLOY; IRON; PARTICULATE MATTER;

ADULT; AIRBORNE PARTICLE; APTITUDE TEST; ARTICLE; BODY BURDEN; CLEARANCE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DUST; FINGER TAPPING TEST; FUME; HALF LIFE TIME; HUMAN; INDUSTRIAL WORKER; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; METAL INDUSTRY; NEUROPSYCHOLOGICAL TEST; OCCUPATIONAL EXPOSURE; OUTCOME ASSESSMENT; PARTICLE SIZE; PARTICULATE MATTER; PREDICTION; PSYCHOLOGIC TEST; STROOP TEST; TIME; TISSUE LEVEL; WECHSLER INTELLIGENCE SCALE; WORD RECOGNITION; AIR POLLUTANT; INTOXICATION; MIDDLE AGED; PSYCHOLOGY; TIME FACTOR;

LURIA;

ADULT; AIR POLLUTANTS, OCCUPATIONAL; HUMANS; IRON; MANGANESE; MANGANESE POISONING; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OCCUPATIONAL EXPOSURE; PARTICULATE MATTER; TIME FACTORS;

EID: 84921370581     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2014.03.015     Document Type: Article

References (31)

1. Andersen M.E., Dorman D.C., Clewell, Taylor M.D., Nong A. Multi-dose-route, multi-species pharmacokinetic models for manganese and their use in risk assessment. J Toxicol Environ Health Part A 2010, 73:217-234.
2. Andersen M.E., Gearhart J.M., Clewell H.J. Pharmacokinetic data needs to support risk assessments for inhaled and ingested manganese. Neurotoxicology 1999, 20:161-172.
3. ATSDR Toxicological Profile for Manganese (Update) 2000, U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, Atlanta, GA.
4. Baldwin M., Bouchard M., Larribe F., Mergler D. Past occupational exposure to airborne manganese in a manganese alloy plant. J Occup Environ Hygiene 2008, 5:426-437.
5. Bouchard M., Mergler D., Baldwin M., Panisset M., Bowler R., Roels H. Neurobehavioral functioning after cessation of manganese exposure: a follow-up after 14 years. AJIM 2007, 50:831-840.
6. Bouchard M., Mergler D., Baldwin M., Panisset M. Manganese cumulative exposure and symptoms: a follow-up study of alloy workers. Neurotoxicology 2008, 29:577-583.
7. Bowler R.M., Gocheva V., Harris M., Ngo L., Abdelouahab N., Wilkinson J., et al. Prospective study on neurotoxic effects in manganese-exposed bridge construction welders. Neurotoxicology 2011, 32:596-605.
8. Bowler R.M., Roels H.A., Nakagawa S., Drezgic M., Diamond E., Park R., et al. Dose-effect relationships between manganese exposure and neurological, neuropsychological and pulmonary function in confined space bridge welders. Occup Environ Med 2007, 64:167-177.
9. Deschamps F.J., Guillaumot M., Raux S. Neurological effects in workers exposed to manganese. J Occup Environ Med 2001, 43:127-132.
10. Dorman D.C., McManus B.E., Parkinson C.U., Manuel C.A., James R.A., Struve M.F., et al. Nasal toxicity of manganese sulfate and manganese phosphate in young male rats following subchronic (13-week) inhalation exposure. Inhal Toxicol 2004, 16:1-8.
11. Elder A., Gelein R., Silva V., et al. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect 2006, 114:1172-1178.
12. Fechter L.D., Johnson D.L., Lynch R.A. The relationship of particle size to olfactory nerve uptake of a non-soluble form of manganese into brain. Neurotoxicology 2002, 23:177-183.
13. Gibbs J.P., Crump K.S., Houck D.P., Warren P.A., Mosley W.S. Focused medical surveillance: a search for subclinical movement disorders in a cohort of U.S. workers exposed to low levels of manganese dust. Neurotoxicology 1999, 20:299-314.
14. Guilarte T.R. Manganese neurotoxicity: new perspectives from behavioral, neuroimaging, and neuropathological studies in humans and non-human primates. Front Aging Neurosci 2013, 5:23. 10.3389/fnagi.2013.00023.
15. Kriebel D., Checkoway H., Pearce N. Exposure and dose modeling in occupational epidemiology. Occup Environ Med 2007, 64:492-498.
16. Levy B.S., Nassetta W.J. Neurologic effects of manganese in humans: a review. Int J Occup Environ Health 2003, 9:153-163.
17. Links J.M., Schwartz B.S., Simon D., Bandeen-Roche K., Stewart W.F. Characterization of toxicokinetics and toxicodynamics with linear systems theory: application to lead-associated cognitive decline. Environ Health Perspect 2001, 109:361-368.
18. Lucchini R., Apostoli P., Pierrone C., Placida D., Albini E., Migliorati P., et al. Long term exposure to low levels of manganese oxides and neurofunctional changes in ferroalloy workers. Neurotoxicology 1999, 20:287-298.
19. Mena I., Horiuchi K., Burke K., Cotzias G.C. Chronic manganese poisoning: individual susceptibility and absorption of iron. Neurology 1969, 19:1000-1006.
20. Mergler D., Huel G., Bowler R., Iregren A., Belanger S., Baldwin M., et al. Nervous system dysfunction among workers with long-term exposure to manganese. Environ Res 1994, 64:151-180.
21. Mergler D., Baldwin M. Early manifestations of manganese neurotoxicity in humans: an update. Environ Res 1997, 73:92-100.
22. Nong A., Teeguarden J.G., Clewell H.J., Dorman D.C., Andersen M.E. Pharmacokinetic modeling of manganese in the rat IV: assessing factors that contribute to brain accumulation during inhalation exposure. J Toxicol Environ Health Part A 2008, 71:413-426.
23. Park R.M., Bowler R.M., Roels H.A. Exposure-response relationship and risk assessment for cognitive deficits in early welding-induced manganism. J Occup Environ Med 2009, 51:1125-1136.
24. Park R.M. Neurobehavioral deficits and parkinsonism in occupations with manganese exposure: a review of methodological issues in the epidemiological literature. Saf Health Work 2013, 4:123-135.
25. Roels H.A., Ghyselen P., Buchet J.P., Ceulemans E., Lauwerys R.R. Assessment of the permissible exposure level to manganese in workers exposed to manganese dioxide dust. Br J Ind Med 1992, 49:25-34.
26. SAS Institute Inc., Cary, NC, USA 2012.
27. Schroeter J.D., Nong A., Yoon M., Taylor M.D., Dorman D.C., Andersen M.E., et al. Analysis of manganese tracer kinetics and target tissue dosimetry in monkeys and humans with multi-route physiologically based pharmacokinetic models. Toxicol Sci 2011, 120:481-498.
28. Teeguarden J.G., Dorman D.C., Covington T.R., Clewell H.J., Andersen M.E. Pharmacokinetic modeling of manganese. I. Dose dependencies of uptake and elimination. J Toxicol Environ Health 2007, 70(Part A):1493-1504.
29. Teeguarden J.G., Dorman D.C., Nong A., Covington T.R., Clewell H.J., Andersen M.E. Pharmacokinetic modeling of manganese. II. Hepatic processing after ingestion and inhalation. J Toxicol Environ Health 2007, 70(Part A):1505-1514.
30. Teeguarden J.G., Gearhart J., Clewell H.J., Covington T.R., Nong A., Andersen M.E. Pharmacokinetic modeling of manganese. III. Physiological approaches accounting for background and tracer kinetics. J Toxicol Environ Health 2007, 70(Part A):1515-1526.
31. Zoni S., Albibi E., Lucchini R. Neuropsychological testing for the assessment of manganese neurotoxicity: a review and a proposal. Am J Ind Med 2007, 50:812-830.